Skip to main content
BMJ Open logoLink to BMJ Open
. 2016 Sep 6;6(9):e010725. doi: 10.1136/bmjopen-2015-010725

Predictors of physical functioning after total hip arthroplasty: a systematic review

L D Buirs 1, L W A H Van Beers 1, V A B Scholtes 1, T Pastoors 1, S Sprague 2, R W Poolman 1
PMCID: PMC5020746  PMID: 27601486

Abstract

Objective

The objective of this systematic review of the literature was to identify the predictors of functional outcome after total hip arthroplasty (THA).

Method

A systematic literature search in Web of Science, CINAHL, EMBASE and PubMed was conducted on 23 June 2015. The articles were selected based on their quality, relevance and measurement of the predictive factor. The level of evidence of all studies was determined using the GRADE rating scheme.

Results

The initial search resulted in 1092 citations. After application of the inclusion and exclusion criteria, 33 articles met our eligibility criteria and were graded. Included studies were classified as level of evidence low (11), moderate (17) or high (5). Of the included studies, 18 evaluated body mass index (BMI), 17 evaluated preoperative physical functions, 15 evaluated age, 15 evaluated gender and 13 evaluated comorbidity. There was strong evidence suggesting an association between BMI, age, comorbidity, preoperative physical functions and mental health with functional outcome after THA. There was weak evidence suggesting an association between quadriceps strength and education with functional outcome after THA. The evidence was inconsistent for associations with gender and socioeconomic status and functional outcome following THA. We found limited evidence suggesting that alcohol consumption, vitamin D insufficiency and allergies were predictors of functional outcome following THA.

Conclusions

We have identified multiple predictors of functional outcome after THA, which will enable general practitioners and orthopaedic surgeons to better predict the improvement in physical functioning for their patients with THA. They can use this information to provide patient-specific advice regarding the referral for THA and the expected outcomes after THA. Further research with consistent measurement tools, outcomes and duration of follow-up across studies is needed to confirm the influence of these factors.

Keywords: total hip, arthroplasty, functional outcome, systematic review, predictors


Strengths and limitations of this study.

  • We have carried out a comprehensive and robust systematic review in accordance with the PRISMA guidelines.

  • We included a range of patient-related predictors and did not limit ourselves to the most common predictors. This led to a broad overview of predictors evaluated.

  • We screened a large number of literature sources, and all reviewing and data extraction was carried out by one author (LDB) and double checked by a second author (LWAHVB).

  • Owing to the heterogeneity across studies regarding measurement tool, predictor and duration of follow-up we could not apply a meta-analysis.

  • The predictors like quadriceps strength, education, socioeconomic status and alcohol consumption were reported only a few times and therefore conclusions cannot be reached.

Introduction

Total hip arthroplasty (THA) is a surgical procedure performed to reduce pain and improve function in patients with osteoarthritis (OA) of the hip. According to the Agency for Healthcare Research and Quality, more than 305 000 total hip replacements are performed each year in the USA.1 Following THA, the majority of patients experience reductions in pain, improvements in function and better health-related quality of life.2 However, not all patients achieve the same level of functional improvement after THA. Specifically, more than 30% of patients undergoing THA report moderate-to-severe activity limitations 2 years post-THA.3 It is unclear which factors are associated with these limitations in function.4 5

In the previous decade, many studies have been published investigating the predictors of functional outcome after THA. Young et al published a systematic review on this topic in 1998. Since then considerable research has been published on predictors of functional outcome which justifies a new systematic review.6 Therefore, we conducted a systematic review of predictors of mid-term and long-term functional outcome after THA.

Methods

Registration

This systematic review is registered at Prospero (http://www.crd.york.ac.uk/PROSPERO/) with registry number CRD42015016929.

Selection criteria

Studies that met the following criteria were included in our review: (1) included patients undergoing a THA; (2) included physical functioning was an outcome measure; (3) had at least one variable that was considered as a predictor of physical functioning and (4) was written in English. We did not select a time period.

Search strategy

With the guidance of an independent medical librarian, we conducted a literature search through four medical databases: Web of Science; CINAHL; EMBASE and PubMed. This literature search was performed on 23 June 2015. In Web of Science we used the following search terms: TOPIC: (total hip arthroplasty) AND TOPIC: (predictor*). In CINAHL we searched for: (MM “Arthroplasty, Replacement, Hip”) AND predictor*. In EMBASE we searched for: exp hip arthroplasty/exp prediction/or exp predictor variable/exp prognosis/or exp functional assessment/or exp treatment outcome/or exp daily life activity/. In PubMed we searched for (“Arthroplasty, Replacement, Hip”(Majr) OR “Hip Prosthesis”(Majr)) AND (predictor* OR risk Factor* OR risk assessment OR predictive value of tests OR prognostic factor* OR Prognostic*) AND (HOOS OR “hip disability and osteoarthritis outcome score” OR WOMAC OR “Western Ontario and McMaster Universities Arthritis Index” OR “Harris hip score” OR HHS OR SF-12 OR short form 12 OR SF 36 OR “short form 36” OR Trendelenburg OR TUG OR “timed up and go” OR “Oxford hip score” OR “IOWA hip score” OR “Functional recovery score” OR FRS OR AFI OR “Hospital for special surgery” OR AAOS OR “Charnley hip score” OR HSS OR LEGS OR “Mayo clinical hip score”). The results of these four different searches were combined in Reference Manager and duplicates were discarded.

Study selection

Two of the authors (LWAHVB and TP) independently screened the titles and abstracts of all the articles using the aforementioned selection criteria. Both reviewers screened the full-text articles of the articles found eligible in the first round. A third author (LDB) compared these results and in case of different opinions, a consensus was reached. The study selection procedure is schematically presented in figure 1.

Figure 1.

Figure 1

Flow chart of the study selection procedure.

Data extraction

One of the authors (LDB) extracted the data, which was double checked by a second author (LWAHVB). From each article, the following information was extracted: (1) predictor variable; (2) author; (3) year of publication; (4) level of evidence; (5) number of patients; (6) measurement tools used; (7) follow-up period; (8) significance level; (9) association between predictor variable and outcome measure; and (10) predictor level of measurement (table 1). The results were categorised by predictor variable.

Table 1.

Methodological quality of included studies

Study Study design Risk of bias Inconsistency Indirectness Imprecision Other considerations Grade
Kessler and Käfer24 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Aranda Villalobos et al31 Observational study Not serious Not serious Not serious Not serious None Low
Nankaku et al26 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Slaven28 Observational study Not serious Not serious Not serious Not serious None Low
Moran et al25 Observational study NA Not serious Not serious Not serious Strong association Moderate
Stevens et al30 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Wang et al32 Observational study Not serious Not serious Not serious Not serious None Moderate
Dowsey et al20 Observational study Serious Not serious Not serious Not serious Strong association Low
Judge et al33 Observational study Not serious Not serious Not serious Not serious Very strong association High
Bergschmidt et al17 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Jones et al22 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Smith et al29 Observational study Not serious Not serious Serious Not serious Strong association Moderate
Judge et al23 Observational study Not serious Not serious Not serious Not serious Very strong association High
Bischoff et al18 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Gandhi et al21 Observational study Serious Not serious Not serious Not serious None Low
Nilsdotter et al27 Observational study Not serious Serious Not serious Not serious Strong association Low
Davis et al19 Observational study Not serious Not serious Not serious Not serious Very strong association High
Hamilton et al35 Observational study Not serious Not serious Not serious Not serious None Low
Quintana et al37 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Nilsdotter and Lohmander36 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Dowsey et al34 Observational study Not serious Not serious Not serious Not serious Very strong association High
Lavernia, 201138 Observational study Serious Not serious Not serious Not serious Strong association Low
Mahomed et al39 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Vogl et al43 Observational study Not serious Serious Not serious Not serious NA Low
Clement et al42 Observational study Not serious Not serious Not serious Not serious Very strong association High
Johansson et al40 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Fortin et al41 Observational study Not serious Not serious Not serious Serious Strong association Low
Badura-Brzoza et al44 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Holstege et al46 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Schafer et al47 Observational study Not serious Not serious Not serious NA Strong association Low
Graves et al48 Observational study Not serious Not serious Not serious Not serious Strong association Moderate
Lavernia, 201449 Observational study Not serious Not serious Not serious NA None Low
Lavernia et al45 Observational study Not serious Not serious Not serious Not serious Strong association Moderate

High: true effect lies close to the estimate of the effect.

Moderate: true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.

Low: true effect may be substantially different from the estimate of effect.

Very low: true effect is likely to be substantially different from the estimate of effect.

GRADE, Grading Recommendations Assessment Development and Evaluation; NA, not applicable.

Methodological quality assessment

The level of evidence of all studies was determined by one of the authors (LDB) using the GRADE rating scheme (http://www.gradeworkinggroup.org).

Measurement tools

We aimed to include all predictors mentioned in previous studies, and did not limit ourselves to the most common predictors. Some of the widely used measurement tools to define functional outcome are the Harris Hip Score (HHS),7 Oxford Hip Score (OHS),8 9 Short Form-36 (SF-36),10 Lower Extremity Functional Scale (LEFS),11 Timed Up and Go (TUG) test12 13 and the Western Ontario and McMaster Universities OA Index (WOMAC).14 We used all these measurement tools as outcome in this study.

Best evidence synthesis

A follow-up period up to 24 months was considered as ‘short term’ and a follow-up period of more than 24 months was considered as ‘long term’. Results were divided into four categories of evidence: strong evidence: at least 60% of the studies, with a minimum of three studies, describing the same significant (p<0.05) association. Weak evidence: (1) only two studies describe the same significant association; (2) three studies describe the same association out of which two are significant and one is not significant (p>0.05). Limited evidence: (1) only one study available; (2) more studies were available of which none found a significant association. Inconsistent evidence: all other scenarios.15 No conclusions can be drawn in this literature review when no or inconsistent evidence is available.

This systematic review conforms to the PRISMA statement.16

Results

Selection and methodological quality

The initial search resulted in 1092 citations (figure 1) and 33 articles met our eligibility criteria. The articles included were designated as level of evidence low (11), moderate (17) or high (5; table 1)

Measures of functional outcome

Multiple outcome measures were used across these studies including the HHS, OHS, SF-36 physical function (PF), LEFS, TUG and the WOMAC score. The follow-up period ranged from 3 to 72 months with an average of 18 (SD 17) months (table 2).

Table 2.

Characteristics of all included studies

Author, year, nr Age baseline N of pts Female (n, %) Inclusion criteria Follow-up time Measurement tool
Badura-Brzoza, 2009, 42 61 (54–75) 156 59 (58%) Primary THA, OA 6 months SF-36 PF
Bergschmidt, 2010, 113 66 (58–74) 100 48 (50%) Primary THA, OA 6–12–24 months HHS
WOMAC
SF-12
Bischoff, 2004, 51 73.1 (65–93) 922 60% OA, primary THA >65 years 3 years WOMAC PF
Clement, 2011, 101 68.1 (65–74) 1312 NA Primary OA, THR 12 months OHS
SF-12
Davis, 2011, 100 69 (34–96) 1617 994 Cemented THA 5 years HHS
SF-36 PF
Dowsey, 2010, 32 68.6/67/65.6 471 60.70% Primary THA OA 12 months HHS
SF-12 PF
Dowsey, 2014, 15 68.4 835 60.10% Primary THA 12 months SF-12
Fortin, 2002, 145 65.7 222 59% Primary THA OA 2 years WOMAC
SF-36
Hamilton, 2012, 17 68.1 1410 57.20% Primary THA OA 6–12 months OHS
SF-12
Gandhi, 2010, 30 63.2 (13.7) 636 53.50% <18 years, primary OA 3.3 years WOMAC
SF-36 PF
Graves, 2014, 29 59.5 459 61.00% THA OA 10. 4 months WOMAC
SF-36
Holstege, 2011, 102 72.7 (6.8) 55 41 (74,5) THA OA 3 months WOMAC PF
Johansson, 2010, 114 67 (7) 75 36 (48%) THA OA 6–12–24 months HHS
WOMAC
SF-36
Jones, 2012, 90 68.2 (10.9) 231 138 (60%) Primary THA 6–36 months WOMAC
Judge, 2013, 14 70 1431 887 (62%) OA 1–6 years OHS
Kessler, 2007, nr 131 63.6 76 44.8 (59%) THA OA 3 months WOMAC
Lavernia, 2014, 73 70 60 48 (80%) Primary THA 3–24 months QWB-7
SF-36 PF
WOMAC
HHS
Lavernia, 2013, 81 62 191 70 Primary THA 12 months WOMAC
SF-36
Lavernia, 2011, 103 61 (15) 532 59% THA 6–7 years SF-26
HHS
WOMAC
Mahomed, 2002, 149 66 (9) 103 57 (55%) THA OA 6 months WOMAC PF
SF-36 PCS
Moran, 2005, 136 68 749 61% Primary THA 6, 18 months HHS
Nankaku, 2013, 83 60.4 204 173 THA OA 6 months Ambulatory status
Nilsdotter, 2002, 147 71 148 83 THA OA 3–6–12 months WOMAC
SF-36
Nilsdotter, 2003, 52 71 211 106 Primary THA 3, 6 years WOMAC PF
Quintana, 2009, 35 69.1 788 381 (48%) Primary THA OA 6–24 months SF-36 PF
WOMAC
Schafer, 2010, 110 61 1007 55% Primary THA 6 months WOMAC
Slaven, 2012, 15 68.2 (8.2) 40 22 (55%) Primary THA 6 months LEFS
Smith, 2012, 92 68.5 (9.9) 1683 NA Primary THA 3 years HHS
Stevens, 2012, 22 70.3 (8.2) 653 74.20% Primary THA, OA 52. 4 weeks WOMAC
Villalobos, 2012, 80 62.39 (13.6) 63 35 (55.55%) Primary THA 3 months HHS
OHS
WOMAC
SF-12 PF
Vogle, 2014, 108 68 321 58% Primary THA 6 months WOMAC
Wang, 2010, 107 61.65 97 62.40% OA/osteonecrosis 3–12–24 months WOMAC

HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; N of pts, number of patients; NA, not applicable; OHS, Oxford Hip Score; PCS, physical component summary scale; PF, physical function; QWB; quality of well-being index; SF-36 PF, Short Form 36 physical function; THA, total hip arthroplasty; THR, total hip replacement; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

Predictive factors of functional outcome

Body mass index

Eighteen studies evaluated body mass index (BMI) as a potential predictor of functional outcome after THA17–34 (table 3). A total of 14 432 patients were included in all articles concerning the impact of BMI, with a mean follow-up time of 22 months. The applied levels of measurement of BMI were continuous, dichotomous or categorical.

Table 3.

Studies reporting BMI as possible predictor of functional outcome after THA

Measurement FU period Significance
Author, year Grade N of pts tool (months) Level (p value) Association Predictor level of measurement
Kessler, 2007 Moderate 76 WOMAC ST (3 m) 0.49 No Cont (BMI)
Villalobos, 2012 Low 63 SF-12 PCS ST (3 m) 0.004* Pos Dich
WOMAC 0.041* Pos (1: BMI>28 2: BMI ?28)
HHS 0.793* No
OHS 0.428* No
Nankaku, 2013 Moderate 204 Ambulatory status ST (6m) 0.06 No Cont (BMI)
Slaven, 2012 Low 40 LEFS ST (6 m) NA Neg Dich
(1: BMI>34 2: BMI ?34)
Moran, 2005 Moderate 749 HHS ST (6 m) 0.02 Neg Cont (BMI)
ST (18 m) 0.001 Neg
Stevens, 2012 Moderate 653 WOMAC ST (12 m) 0.001 Neg Cont (BMI)
Wang, 2010 Moderate 97 WOMAC ST (12 m) 0.11 No Cont (BMI)
Dowsey, 2010 Low 471 HHS ST (12 m) <0.01 Neg Cat (3)
SF-12 PCS 0.05 Neg (1: BMI<30 2: BMI 30–39 3: BMI≥40)
Dowsey, 2014 High 835 HHS ST (12 m) <0.0001 Neg Cont (BMI)
Judge, 2014 High 4413 OHS ST (12 m) 0.003 Neg Cat (5)
(1: BMI 18.5–25 2: BMI 25–30 3: BMI 30–35
4: BMI 35–40 5: BMI>40)
Bergschmidt, 2010 Moderate 100 HHS ST (24 m) 0.007 Neg Cat (3)
(1: BMI<26 2: BMI 26–29 3: BMI>29)
Jones, 2012 Moderate 231 WOMAC ST (6 m) 0.001 Neg Dich
LT (36 m) No No (1: BMI>35 2: BMI ?35)
Smith, 2012 Moderate 1683 HHS LT (36 m) <0.01 Neg Cont (BMI)
Judge, 2013 High 1431 OHS LT (36 m) <0.001 Neg Cont (BMI)
Bischoff, 2004 Moderate 922 WOMAC PF LT (36 m) NA Neg Cont (BMI)
Gandhi, 2010 Low 636 WOMAC LT (39 m) 0.06 No Cont (BMI)
Nilsdotter, 2003 Low 211 WOMAC PF LT (42 m) 0.03 Neg Cont (BMI)
Davis, 2011 High 1617 HHS LT (60 m) <0.001 Neg Cont (BMI)

All significant results are bold; studies that used change in function as outcome are marked with *.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The measurement tools used to determine the functional outcome were the WOMAC score, HHS, OHS, LEFS, SF-12 PF and the ambulatory status. The classification of a high BMI ranged from >28 to >35 kg/m2.

Of the 18 studies, 13 found a significant association.17–19 22 23 25 27–31 33 34 Twelve studies evaluated the short-term functional outcome of which eight studies17 20 22 25 28 30 33 34 found a significant negative association and one article had a significant positive association.31 Of the seven studies evaluating the long-term functional outcome, five articles found a significant negative association.18 19 23 27 29 Studies were designated as level of evidence low (5), moderate (9) or high (4).

Since more than 60% of the studies report a significant negative association, there is strong evidence of a negative association between BMI and short-term and long-term functional outcomes after THA. These results were consistent when we only considered the studies with high or moderate levels of evidence according to GRADE.

Age

Fifteen studies evaluated age as a possible predictor of functional outcome after THA17 18 21 23 24 26–30 32 34–37 (table 4). A total of 9234 patients were included in all studies that identified age as a possible predictor, with a mean follow-up time of 19 months. The applied levels of measurement of age were continuous, dichotomous or categorical.

Table 4.

Studies reporting age as possible predictor of functional outcome after THA

 
Measurement FU period Significance
Author, year Grade N of pts tool (months) Level (p value) Association Predictor level of measurement
Kessler, 2007 Moderate 76 WOMAC ST (3 m) 0.03 Neg Cont (age)
Nankaku, 2013 Moderate 204 Ambulatory status ST (6 m) Yes Neg Dich
(1: age >67.5 2: age ?67.5 )
Slaven, 2012 Low 40 LEFS ST (6 m) No No Dich
(1: age >68.5 2: age ?68.5)
Hamilton, 2012 Low 1410 OHS ST (6 m) X No Cont (age)
SF-12 ST (12 m) X No
Quintana, 2009 Moderate 788 WOMAC PF ST (6 m) 0.41 No Dich
ST (24 m) 0.001 Neg (1: age >70 2: age ?70)
Stevens, 2012 Moderate 653 WOMAC ST (12 m) 0.01 Neg Cont (age)
Wang, 2010 Moderate 97 WOMAC ST (12 m) No No Cont (age)
Dowsey, 2014 High 835 HHS ST (12 m) <0.0001 Neg Cont (age)
SF-12 PCS 0.003 Neg
Nilsdotter, 2002 Moderate 148 WOMAC PF ST (12 m) 0.004 Neg Dich
SF-36 0.002 Neg (1: age >72 2: age ?72)
Bergschmidt, 2010 Moderate 100 HHS ST (12 m) >0.097 No Cat (3)
WOMAC >0.097 No (1: age <60 2: age 60–69 3: age >69
SF-12 >0.097 No
Bischoff, 2004 Moderate 922 WOMAC PF LT (36 m) X No Dich
(1: age >75 2: age ?75)
Judge, 2013 High 1431 OHS LT (36 m) NA Neg Cat (3)
(1: age <50 2: age 50–60 3: age >60
Smith, 2012 Moderate 1683 HHS LT (36 m) <0.001 Neg Cont (age)
Nilsdotter, 2003 Low 211 WOMAC PF LT (43 m) 0.002 Neg Cont (age)
Gandhi, 2010 Low 636 WOMAC LT (39 m) <0.05 Neg Cont (age)
SF-36 <0.05

All significant results are bold.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The measurements tools used to determine the functional outcome were the WOMAC score, HHS, OHS, SF-36 PF, SF-12 PF and the ambulatory status. Different classifications of greater age were used, ranging from >60 to >75 years.

Of the 15 studies, 10 found a significant association.21 23 24 26 27 29 30 34 36 37 Ten studies evaluated the short-term functional outcome of which six studies found a significant negative association.24 26 30 34 36 37 The other four studies did not find a significant association. Of the six studies evaluating the long-term functional outcome, five studies found a significant negative association.21 23 29 36 37 Studies were designated as level of evidence low (4), moderate (9) or high (2).

Since more than 60% of the studies report a significant negative association, there is strong evidence of a negative association between high age and short-term and long-term functional outcomes after THA. These results were consistent when we only considered the studies with high or moderate levels of evidence according to GRADE.

Gender

Fifteen studies evaluated gender as a possible predictor of functional outcome after THA17 18 21 22 24 26–30 32 34 36–38 (table 5). A total of 7156 patients were included in all studies that evaluated gender as a possible predictor, with a mean follow-up time of 23.3 months. The measurement tools used to determine the functional outcome included the WOMAC score, HHS, LEFS, SF-36 and the ambulatory status.

Table 5.

Studies reporting gender as possible predictor of functional outcome after THA

Measurement FU period Significance
Author, year Grade N of pts tool (months) Level (p value) Association Predictor level of measurement
Kessler, 2007 Moderate 76 WOMAC ST (3 m) NA No Dich
(1: men 2: woman)
Nilsdotter, 2002 Moderate 148 WOMAC ST (3 m) 0.7 No Dich
SF-36 ST (12 m) (1: men 2: woman)
Nankaku, 2013 Moderate 204 Ambulatory status ST (6 m) 0.10 No Dich
(1: men 2: woman)
Slaven, 2012 Low 40 LEFS ST (6 m) 0.039 Pos, woman Dich
(1: men 2: woman)
Quintana, 2009 Moderate 788 SF-36 PF ST (6 m) NA Pos, men Dich
ST (24 m) NA No (1: men 2: woman)
Bergschmidt, 2010 Moderate 100 HHS ST (12 m) NA No Dich
(1: men 2: woman)
Stevens, 2012 Low 653 WOMAC ST (12 m) 0.002 Pos, men Dich
(1: men 2: woman)
Dowsey, 2014 High 835 HHS ST (12 m) 0.06 No Dich
(1: men 2: woman)
Wang, 2010 Moderate 97 WOMAC ST (16.8 m) 0.0001 Pos, men Dich
(1: men 2: woman)
Bischoff, 2004 Moderate 922 WOMAC PF LT (36 m) No No Dich
(1: men 2: woman)
Jones, 2012 Moderate 231 WOMAC LT (36 m) 0.118 No Dich
(1: men 2: woman)
Smith, 2012 Moderate 1683 HHS LT (36 m) <0.001 Pos, men Dich
(1: men 2: woman)
Gandhi, 2010 Low 636 WOMAC LT (39 m) No No Dich
SF-36 PF <0.05 Pos, woman (1: men 2: woman)
Lavernia, 2011 Low 532 WOMAC PF LT (42 m) <0.001* Pos, woman Dich
(1: men 2: woman)
Nilsdotter, 2003 Low 211 WOMAC PF LT (66 m) 0.37 No Dich
(1: men 2: woman)

All significant results are bold; studies that used change in function as outcome are marked with *.

BMI, body mass index; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

Of the 15 studies, 7 found a statistically significant association between preoperative physical function and functional outcome.21 28–30 32 37 38 Nine studies evaluated the short-term functional outcome of which four studies found a significant association.28 30 32 37 Six studies evaluated the long-term functional outcome of which three found a significant association.21 29 38 All studies were designated as level of evidence low (5), moderate (9) or high (1).

In four of the seven studies with a significant outcome, being male predicted a better outcome29 30 32 37 whereas three studies reported being female as a predictor of better functional outcome.21 28 38 This demonstrates inconsistent evidence for an association between gender and functional outcome after THA.

Preoperative physical function

Seventeen studies evaluated preoperative physical function as a possible predictor of functional outcome after THA17 23 25–29 32 34–37 39–43 (table 6). A total of 9689 patients were included in all studies that evaluated preoperative physical function, with a mean follow-up time of 16 months. The applied levels of measurement of preoperative physical function were continuous, dichotomous or categorical.

Table 6.

Studies reporting preoperative physical function as possible predictor of functional outcome after THA

 
Measurement FU period Significance
Author, year Grade N of pts tool (months) Level (p value) Association Predictor level of measurement
Quintana, 2009 Moderate 788 WOMAC PF ST (6 m) <0.001 Yes Cont (WOMAC+SF-36)
SF-36 PF
Slaven, 2012 Low 40 TUG ST (6 m) NA No Dich
(successful/unsuccessful)
Mahomed, 2002 Moderate 103 WOMAC PF+P ST (6 m) <0.05 Yes Cont (WOMAC+SF-36)
SF-36 PF <0.05
Hamilton, 2012 Low 1410 OHS ST (6 m) Yes Yes Cont (OHS)
SF-12 ST (12 m)
Nankaku, 2013 Moderate 204 Ambulatory status ST (6 m) NA Yes Dich (TUG score 10)
Vogl, 2014 Low 281 WOMAC ST (6 m) NA Yes Cont (WOMAC)
Bergschmidt, 2010 Moderate 100 WOMAC ST (12 m) <0.022 Yes Cat (3)
SF-36 0.003 1: HHS<48 2: HHS 48–59 3: HHS>59
Clement, 2010 High 1312 OHS ST (12 m) 0.001* Yes Cont (OHS)
SF-12
Johansson, 2010 Moderate 75 HHS ST (12 m) ?0.006 Yes Cat (3)
WOMAC <0.001 Yes 1: HHS<45 2: HHS 45–55 3: HHS>55
SF-36 ?0.005 Yes
Nilsdotter, 2002 Moderate 148 WOMAC ST (12 m) <0.0001 Yes Dich
SF-36 Low quartile vs high quartile WOMAC
Dowsey, 2014 High 835 HHS ST (12 m) <0.0001 Yes Cont (HHS)
Wang, 2010 Moderate 97 WOMAC ST (16.8 m) 0.0001 Yes Cont (WOMAC PF)
Moran, 2005 Moderate 749 HHS ST (18 m) NA Yes Cont
Fortin, 2002 Low 222 WOMAC ST (24 m) NA Yes Dig (1: high WOMAC 2: low WOMAC)
SF-36 NA Yes
Smith, 2012 Moderate 1683 HHS LT (36 m) <0.001 Yes Cont (HHS)
Nilsdotter, 2003 Low 211 WOMAC PF LT (42 m) 0.007 Yes Dich
Low quartile vs high quartile SF-36 PF
Judge, 2013 High 1431 OHS LT (60 m) <0.001 Yes Cont (OHS)

All significant results are bold.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The WOMAC score14 was the measurement tool most used to determine the preoperative physical function.17 27 32 36 37 39–41 43 Other measurement tools used were the HHS, TUG, OHS, SF-36, SF-12 and the ambulatory status.

Of the 17 studies, 16 found a statistically significant correlation between preoperative physical function and the functional outcome. Fourteen studies evaluated the short-term outcome of which 13 reported a significant association. Three studies evaluated the long-term outcome; all three found a significant association. The only study that did not report a significant association, was a study on a small patient group that used the TUG to determine the preoperative physical function.28 Studies were designated as level of evidence low (5), moderate (9) or high (3).

As more than 60% of the studies report a significant negative association, there is strong evidence of a short-term and long-term association between the preoperative physical function and the functional outcome after THA.

Comorbidity

Thirteen studies evaluated comorbidity as a possible predictor of functional outcome after THA (table 7). A total of 9363 patients were included in all studies that evaluated comorbidity as a possible predictor, with a mean follow-up time of 23.3 months. The applied levels of measurement of preoperative status were continuous, dichotomous or categorical.

Table 7.

Studies reporting comorbidity status as possible predictor of functional outcome after THA

 
Measurement FU period Significance  
Author, year Grade N of pts tool (months) level (p value) Association Predictor level of measurement
Quintana, 2009 Moderate 788 WOMAC PF ST (6 m) NA No Cat (3)
SF-36 PF NA 1: 0 comorbidities 2: 1–2 comorbidities 3: >2 comorbidities
Mahomed, 2002 Moderate 103 WOMAC PF+P ST (6 m) <0.05 Neg Cont
(number of comorbidities)
Moran, 2005 Moderate 749 HHS ST (6 m) NA Neg Dich
ST (18 m) (presence of coronary heart disease and
previous thromoembolism)
Stevens, 2012 Moderate 653 WOMAC ST (12 m) 0.01 Neg Cat (3)
1: 0 comorbidities 2: 1–2 comorbidities 3: >2 comorbidities
Clement, 2010 High 1312 OHS ST (12 m) 0.01 Neg Cont
SF-12 (number of comorbidities)
Dowsey, 2014 High 835 HHS ST (12 m) 0.0001 Neg Cont
(age-adjusted CCI)
Wang, 2010 Moderate 97 WOMAC ST (16.8 m) 0.0246 Neg Dich
(1: >0 comorbidities 2: 0 comorbidities)
Jones, 2012 Moderate 231 WOMAC LT (36 m) 0.012 Neg Dich
(1; 0 cardiac diseases
2: >0 cardiac diseases)
Bischoff, 2004 Moderate 922 WOMAC PF LT (36 m) NA Neg Dich
(1; >2 chronic diseases
2. 0–1 chronic diseases)
Smith, 2012 Moderate 1683 HHS LT (36 m) <0.001 Neg Cont
(ASA grade)
Gandhi, 2010 Low 636 WOMAC LT (39 m) <0.05 Neg Cont
SF-36 PF (number of comorbidities)
Nilsdotter, 2003 Low 211 WOMAC PF LT (42 m) 0.08 No Dich
(1: >1 comorbidities 2: 0–1 comorbidities)
Judge, 2013 High 1431 OHS LT (60 m) 0.001 Neg Cont
(number of comorbidities)

All significant results are bold.

BMI, body mass index; Cat, categorical; CCI, Charlson comorbidity index; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; THA, total hip arthroplasty; WOMAC, Western Ontario and Mcmaster Universities Osteoarthritis Index.

The measurement tools used to determine the functional outcome were the WOMAC score, HHS, LEFS, SF-36 and the ambulatory status. Most studies used the number of comorbidities or American Society of Anesthestiologists (ASA) grade as predictor of functional outcome. Other studies used the presence of a specific comorbidity as a predictor like cardiac disease, coronary heart disease and thromboembolism.

Of the 13 studies, 11 found a significant negative association.18 21 22 25 27 29 30 32–34 37 39 42 Seven studies evaluated the short-term outcome of which six reported a significant negative association.22 23 25 30 32 34 39 42 Six studies evaluated the long-term outcome, of which five found a significant negative association.18 21–23 29 All articles were designated as level of evidence low (2), moderate (8) or high (3).

Since more than 60% of the studies report a significant negative association, there was strong evidence of a negative association between comorbidities and short-term and long-term functional outcomes after THA.

Other predictors

The predictors that were evaluated in five studies or less are displayed in table 8.

Table 8.

All predictors that are evaluated in five studies or less

Predictor Author, year Grade N of pts Measurement tool FU-period (months) Significance level (p value) Association Predictor level of measurement
Badura-Brzoza,
Mental health 2009 Moderate 102 SF-36 PCS ST (6 m) 0.005 Neg Cont
(anxiety as a trait)
Quintana, 2009 Moderate 788 SF-36 PF ST (6 m) <0.001 Yes Cont
WOMAC P ST (24 m) 0.002 (SF-36 MH score)
Dowsey, 2014 High 835 HSS ST (12 m) <0.0001 Yes Cont
(SF-12 MH score)
Bischoff, 2004 Moderate 922 WOMAC PF LT (36 m) NA Yes Dich
(1: >60 pts on the SF-36 MH score
2: ?60 pts on SF-36 MH score)
Judge, 2013 High 916 OHS ST (12 m) 0.045 Yes Cont
LT (60 m) (SF-36 MH score)
Alcohol Bischoff, 2004 Moderate 914 WOMAC PF LT (36 m) NA No Dich
consumption (1: >1 alcoholic drinks per day
2: 0–1 alcoholic drinks per day)
Lavernia, 2014 Low 191 WOMAC LT (72 m) NA No Cat (3)
(1: non-drinkers 2: occasional drinkers
3: moderate drinkers)
Quadriceps Holstege, 2011 Moderate 55 WOMAC PF ST (3 m) 0.004 Pos Cont
strength (knee extensor strength)
Nankaku, 2013 Moderate 204 Ambulatory status ST (6 m) NA Pos Dich
(1: >1.25 N m/kg 2: ?1.25 m/kg
knee extensor strength)
Education Schafer, 2010 Low 1007 WOMAC ST (6 m) NA Pos Dich
(1; >12 years school 2: <9 years school)
Mahomed, 2002 Moderate 103 WOMAC PF+P ST (6 m) 0.007 Pos Cont
(level of education)
Bischoff, 2004 Moderate 922 WOMAC PF LT (36 m) NA Pos Dich
(1: college education 2: less
than college education)
Socioeco Dowsey, 2014 High 835 HHS LT (12 m) 0.63 No Cont
nomic status (SES score)
Allergies Graves, 2014 Moderate 459 WOMAC PF ST (6.5 m) 0.04 Neg Dich
SF-36 PCS 0.0002 (>3 allergies)
Vitamin D Lavernia, 2013 Moderate 60 HHS ST (11 m) 0.002 Neg Dich (25-hydroxyvitamin D3)
insufficiency WOMAC 0.478 (1; >30 ng/mL 2: <30 ng/mL)

All significant results are bold.

BMI, body mass index; Cat, categorical; Cont, continuous; Dich, dichotomous; FU, follow-up; HHS, Harris Hip Score; LEFS, Lower Extremity Functional Scale; LT, long-term; N of pts, number of patients; NA, not applicable; Neg, negative; OHS, Oxford Hip Score; PCS, physical component summary scale; Pos, positive; SF-36 PF, Short Form 36 physical function; ST, short-term; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.

Five studies evaluated mental health as a possible predictor of functional outcome after THA, with a total of 3563 patients.18 23 34 37 44 All four studies evaluating the short-term functional outcome found a significant positive association.23 34 37 44 Both studies that evaluated the long-term outcome found a significant positive association. Since more than 60% of the studies report a significant positive association, there is strong evidence of an association between good mental health and better short-term physical function outcome after THA. Since only two studies evaluated the long-term outcome, this evidence is weak.

Two studies evaluated alcohol consumption as a predictor of functional outcome.18 45 Neither of them found a significant result and therefore none show evidence of an association. The two studies evaluating quadriceps strength as a possible predictor26 46 looked at the short-term functional outcome and both found a significant association. Therefore, the evidence for an association is weak.

All three studies that evaluated educational level as a possible predictor found a significant association.18 39 47 Two studies evaluated the short-term outcome and both found a significant association.39 47 One study evaluated the long-term effect and found a significant association.18 All three studies used the WOMAC score to measure the functional outcome. These results show weak evidence for a short-term association, and incomplete evidence for a long-term association.

One study reported socioeconomic status (SES) as a predictor, using the SES score as measurement tool.34 They did not find a significant result and therefore show limited evidence of an association.

The influence of having more than three allergies on the short-term functional outcome was reported in one study.48 Patients with allergies had diminished improvements on SF-36 PCS and WOMAC scores 6.5 months after THA. There was limited evidence of an association between having more than three allergies and functional outcome.

Vitamin D insufficiency as a predictor of functional outcome after THA was evaluated in one study.49 A preoperative 25-hydroxyvitamin D3 plasma level of under 30 ng/mL, predicted a worse HHS 11 months postoperative. Since no other studies evaluated vitamin D insufficiency as a possible predictor, this result shows limited evidence of an association.

Discussion

In this systematic literature review, we sought to provide a clear overview of a range of patient-related predictors of functional outcome after THA.

Key findings

Our review found strong evidence of an association of BMI, age, comorbidity, preoperative physical function and mental health with functional outcome after THA. Weak evidence was found for the predictors like quadriceps strength and education. Inconsistent evidence was found for the predictors like gender and SES. Limited evidence was found for the predictors like alcohol consumption, vitamin D insufficiency and allergies.

In our review, 13 studies found a significant negative association between BMI and functional outcome after THA. A prior review of Young et al6 found the same significant negative association. Although the review of Young et al and our current review come to the same conclusion, the clinical impact of this outcome is still questionable. A large study by Judge et al33 showed a small significant correlation between high BMI and worse functional outcome, but concluded that the total improvement in function outweighs the small lack of improvement caused by high BMI.

Although our review shows strong evidence of an association between BMI and functional outcome, different classifications of high BMI were used. Owing to these different classifications, it is difficult to define a specific BMI that predicts who will do well after THA. We could not conduct a meta-analysis since different classifications of BMI were used and there was heterogeneity in outcome instruments. Therefore, future research on the impact of BMI should use clearly defined outcomes that are consistent across studies.

In our review, 8 of the 14 studies found an association between higher age and poorer functional outcome; therefore, age is an important factor predicting functional outcome. Some articles used a linear regression analysis for age. When looking at age, it is interesting to see the effect of high age, and also of low age. Therefore, linear regression analysis might not be the best statistical analysis with variables as age or BMI. There is no consensus among studies about what specific age limit is recommended for THA. This current review shows inconclusive evidence of an association between gender and functional outcome because 6 out of 14 studies found a statistically significant result.

Three studies reported being female led to a better functional outcome.21 28 38 The other four significant articles found the opposite result where being male had a positive association with functional outcome after THA.29 30 32 37 The results are contradictory and the differences may be attributable to confounding factors.

Preoperative physical function was found to be a strong predictor of long-term functional outcome. With the exception of one study reporting the TUG test as an outcome, better preoperative physical function was consistently associated with better long-term physical function.28 This might be due to the use of TUG score as measurement tool.28 The WOMAC score was the measurement tool most used to define the preoperative status (nine times).17 27 32 36 37 39–41 43 Other preoperative measurement tools that were good predictors of functional outcome were the HHS, OHS, SF-12 PF, SF-36 PF and the ambulatory status.

Of the 13 studies that evaluated comorbidity as a possible predictor of functional outcome, 11 found a significant negative association.18 21–23 25 29 30 32 34 37 39 42 Comorbidity can be measured in several ways, for example, the number of comorbidities, the presence of a specific comorbidity, the Charlson index50 and the Elixhauser comorbidity measure.51 Comorbidities can affect the true functional outcome after THA but can also affect the score on the measurement tool. For example, if a patient is unable to walk to the grocery store after a THA due to a lung disease, his functional outcome score will be lower despite a possible good functioning total hip. Except for one article, all studies found a significant negative effect. Therefore, having comorbidities can be seen as a predictor of negative functional outcome.

All five studies that evaluated mental health as a predictor of functional outcome found a statistically significant positive association. Four of these studies used SF-36 MH52 as the measurement tool to measure mental health.18 23 34 37 These results show strong evidence of a positive association between mental health and short-term functional outcome after THA. The two studies reporting quadriceps strength as a predictor had both small sample sizes which can affect the external validity of the studies.26 46 Therefore, this evidence is weak and more research must be carried out on the effect of quadriceps strength.

Three studies evaluated education as predictor of functional outcome. Mahomed et al39 and Bischoff et al18 used the level of school education as a predictor, and Schäfer et al47 used years of education as a predictor. Since education is in part a surrogate of SES, this might also indicate that low SES is a factor associated with poor functional outcome. Dowsey et al34 however did not find a correlation between SES and functional outcome. Future research is needed on various components of SES to specify the impact on functional outcome. As only one study evaluated each of the allergies48 and vitamin D insufficiency49 as possible predictors of functional outcome, no conclusions can be drawn.

Previous systematic reviews

The previous systematic review of Young et al concluded that important research remained to be done to examine the magnitude and interaction of patient factors on the outcome of THA.6 The review of Young et al used only one database (MEDLINE) and is more than 15 years old. Young et al also looked at implant survivorship. In our systematic review, we used multiple databases (Web of Science, CINAHL; EMBASE and PubMed) and reported only patient-related predictors evaluated in the literature.

Strengths and limitations

We included a range of patient-related predictors and did not limit ourselves to the most common predictors. This led to a broad overview of predictors evaluated. The reason we could not apply a meta-analysis is because of the heterogeneity across studies regarding measurement tools, predictors and duration of follow-up. Not all studies used in this review adjusted their outcomes for potential confounders. Therefore, some outcomes may be due to confounding factors. A limitation of our review is that we looked at functional outcome without including pain. Some patients will not see an improvement in their function after THA, but will lose the hip-related pain. For this reason especially people with a high BMI and older age can benefit from THA, without improving the function of the hip. Some predictors such as quadriceps strength, education, SES and alcohol consumption are reported only a few times and therefore conclusions cannot be reached. More research in large data sets is needed to draw definitive conclusions on these predictors.

Implications for practice

Our review provides a clear overview of the current literature on the predictors for physical functioning after THA. Orthopaedic surgeons and general practitioners can use this information to predict the improvement in physical functioning of their patients and it enables them to provide patient-specific advice on THA.

Implications for future research

In the future, we suggest studies that evaluate possible predictors of functional outcome after THA to use similar measurement tools, outcomes and durations of follow-up. In that way a meta-analysis can be applied and the influence of these factors can be specified.

Conclusion

This review shows that several patient-related characteristics can predict the functional outcome after THA. It shows strong evidence of an association between BMI, age, comorbidity, preoperative physical function and mental health with functional outcome after THA. Weak evidence suggested that quadriceps strength and education were predictive of functional outcomes after THA. Inconsistent evidence was found for the predictors like gender and SES. Alcohol consumption, vitamin D insufficiency and allergies showed limited evidence predicting functional outcome after THA. Understanding predictors will help orthopaedic surgeons and general practitioners predict the outcomes in physical functioning after THA; they can use this information to provide patient-specific advice and target care for patients with THA. Further well-conducted cohort studies are necessary to confirm these findings.

Acknowledgments

The authors would like to thank the medical librarian Bert Berenschot at OLVG for his help with the literature search.

Footnotes

Contributors: LDB, LWAHVB, VABS, TP, SS and RWP made substantial contributions to the conception and design, or acquisition of data, or analysis and interpretation of data. LDB, LWAHVB, VABS, SS and RWP have been involved in drafting the manuscript or revising it critically for important intellectual content. All authors read and approved the final manuscript.

Competing interests: LWAHVB beers report grants from Link/Lima, grants from Stryker, outside the submitted work. SS reports employment/salary from McMaster University, employment/salary from Global Research Solutions, outside the submitted work. VABS reports grants from Link/Lima, grants from Stryker, grants from NuVasive, grants from Zonmw, grants from Achmea and grants from Tornier, outside the submitted work. RWP reports grants from Link/Lima, grants from Stryker, grants from NuVasive, grants from Zonmw, grants from Achmea and grants from Tornier, outside the submitted work.

Provenance and peer review: Not commissioned; externally peer reviewed.

Data sharing statement: No additional data are available.

References

  • 1.Bernstein J, Derman P. Dramatic increase in total knee replacement utilization rates cannot be fully explained by a disproportionate increase among younger patients. Orthopedics 2014;37:e656–9. 10.3928/01477447-20140626-58 [DOI] [PubMed] [Google Scholar]
  • 2.Judge A, Cooper C, Williams S et al. . Patient-reported outcomes one year after primary hip replacement in a European Collaborative Cohort. Arthritis Care Res (Hoboken) 2010;62:480–8. 10.1002/acr.20038 [DOI] [PubMed] [Google Scholar]
  • 3.Singh JA, Lewallen DG. Predictors of activity limitation and dependence on walking aids after primary total hip arthroplasty. J Am Geriatr Soc 2010;58:2387–93. 10.1111/j.1532-5415.2010.03182.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Williams O, Fitzpatrick R, Hajat S et al. . Mortality, morbidity, and 1-year outcomes of primary elective total hip arthroplasty. J Arthroplasty 2002;17:165–71. 10.1054/arth.2002.29389 [DOI] [PubMed] [Google Scholar]
  • 5.MacWilliam CH, Yood MU, Verner JJ et al. . Patient-related risk factors that predict poor outcome after total hip replacement. Health Serv Res 1996;31:623–38. [PMC free article] [PubMed] [Google Scholar]
  • 6.Young NL, Cheah D, Waddell JP et al. . Patient characteristics that affect the outcome of total hip arthroplasty: a review. Can J Surg 1998;41:188–95. [PMC free article] [PubMed] [Google Scholar]
  • 7.Nilsdotter A, Bremander A. Measures of hip function and symptoms: Harris Hip Score (HHS), Hip Disability and Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), Lequesne Index of Severity for Osteoarthritis of the Hip (LISOH), and American Academy of Orthopedic Surgeons (AAOS) Hip and Knee Questionnaire. Arthritis Care Res (Hoboken) 2011;63(Suppl 11):S200–7. 10.1002/acr.20549 [DOI] [PubMed] [Google Scholar]
  • 8.Gosens T, Hoefnagels NHM, de Vet RCW et al. . The “Oxford Heup Score”: the translation and validation of a questionnaire into Dutch to evaluate the results of total hip arthroplasty. Acta Orthop 2005;76:204–11. 10.1080/00016470510030580 [DOI] [PubMed] [Google Scholar]
  • 9.Dawson J, Fitzpatrick R, Carr A et al. . Questionnaire on the perceptions of patients about total hip replacement. J Bone Joint Surg Br 1996;78:185–90. [PubMed] [Google Scholar]
  • 10.Brazier JE, Harper R, Jones NM et al. . Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ 1992;305:160–4. 10.1136/bmj.305.6846.160 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Binkley JM, Stratford PW, Lott SA et al. . The Lower Extremity Functional Scale (LEFS): scale development, measurement properties, and clinical application. North American Orthopaedic Rehabilitation Research Network. Phys Ther 1999;79:371–83. [PubMed] [Google Scholar]
  • 12.Podsiadlo D, Richardson S. The timed “Up & Go”: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39:142–8. 10.1111/j.1532-5415.1991.tb01616.x [DOI] [PubMed] [Google Scholar]
  • 13.Mathias S, Nayak US, Isaacs B. Balance in elderly patients: the “get-up and go” test. Arch Phys Med Rehabil 1986;67:387–9. [PubMed] [Google Scholar]
  • 14.Bellamy N, Buchanan WW, Goldsmith CH et al. . Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988;15:1833–40. [PubMed] [Google Scholar]
  • 15.Singh AS, Mulder C, Twisk JW et al. . Tracking of childhood overweight into adulthood: a systematic review of the literature. Obes Rev 2008;9:474–88. 10.1111/j.1467-789X.2008.00475.x [DOI] [PubMed] [Google Scholar]
  • 16.Moher D, Liberati A, Tetzlaff J et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9. 10.7326/0003-4819-151-4-200908180-00135 [DOI] [PubMed] [Google Scholar]
  • 17.Bergschmidt P, Bader R, Finze S et al. . Impact of preoperative variables on the functional and radiological outcome of an uncemented femoral stem: a prospective two-year follow-up. Hip Int 2010;20:187–97. [DOI] [PubMed] [Google Scholar]
  • 18.Bischoff-Ferrari HA, Lingard EA, Losina E et al. . Psychosocial and geriatric correlates of functional status after total hip replacement. Arthritis Rheum 2004;51:829–35. 10.1002/art.20691 [DOI] [PubMed] [Google Scholar]
  • 19.Davis AM, Wood AM, Keenan AC et al. . Does body mass index affect clinical outcome post-operatively and at five years after primary unilateral total hip replacement performed for osteoarthritis? A multivariate analysis of prospective data. J Bone Joint Surg Br 2011;93:1178–82. 10.1302/0301-620X.93B9.26873 [DOI] [PubMed] [Google Scholar]
  • 20.Dowsey MM, Liew D, Stoney JD et al. . The impact of obesity on weight change and outcomes at 12 months in patients undergoing total hip arthroplasty. Med J Aust 2010;193:17–21. [DOI] [PubMed] [Google Scholar]
  • 21.Gandhi R, Dhotar H, Davey JR et al. . Predicting the longer-term outcomes of total hip replacement. J Rheumatol 2010;37:2573–7. 10.3899/jrheum.100149 [DOI] [PubMed] [Google Scholar]
  • 22.Jones CA, Cox V, Jhangri GS et al. . Delineating the impact of obesity and its relationship on recovery after total joint arthroplasties. Osteoarthr Cartil 2012;20:511–18. 10.1016/j.joca.2012.02.637 [DOI] [PubMed] [Google Scholar]
  • 23.Judge A, Arden NK, Batra RN et al. . The association of patient characteristics and surgical variables on symptoms of pain and function over 5 years following primary hip-replacement surgery: a prospective cohort study. BMJ Open 2013;3:pii: e002453 10.1136/bmjopen-2012-002453 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Kessler S, Käfer W. Overweight and obesity: two predictors for worse early outcome in total hip replacement? Obesity (Silver Spring) 2007;15:2840–5. 10.1038/oby.2007.337 [DOI] [PubMed] [Google Scholar]
  • 25.Moran M, Walmsley P, Gray A et al. . Does body mass index affect the early outcome of primary total hip arthroplasty? J Arthroplasty 2005;20:866–9. 10.1016/j.arth.2005.02.008 [DOI] [PubMed] [Google Scholar]
  • 26.Nankaku M, Tsuboyama T, Akiyama H et al. . Preoperative prediction of ambulatory status at 6 months after total hip arthroplasty. Phys Ther 2013;93:88–93. 10.2522/ptj.20120016 [DOI] [PubMed] [Google Scholar]
  • 27.Nilsdotter AK, Petersson IF, Roos EM et al. . Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study. Ann Rheum Dis 2003;62:923–30. 10.1136/ard.62.10.923 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Slaven EJ. Prediction of functional outcome at six months following total hip arthroplasty. Phys Ther 2012;92:1386–94. 10.2522/ptj.20110484 [DOI] [PubMed] [Google Scholar]
  • 29.Smith GH, Johnson S, Ballantyne JA et al. . Predictors of excellent early outcome after total hip arthroplasty. J Orthop Surg Res 2012;7:13 10.1186/1749-799X-7-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Stevens M, Paans N, Wagenmakers R et al. . The influence of overweight/obesity on patient-perceived physical functioning and health-related quality of life after primary total hip arthroplasty. Obes Surg 2012;22:523–9. 10.1007/s11695-011-0483-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Aranda Villalobos P, Navarro-Espigares JL, Hernández-Torres E et al. . Body mass index as predictor of health-related quality-of-life changes after total hip arthroplasty: a cross-over study. J Arthroplasty 2013;28:666–70. 10.1016/j.arth.2012.07.011 [DOI] [PubMed] [Google Scholar]
  • 32.Wang W, Morrison TA, Geller JA et al. . Predicting short-term outcome of primary total hip arthroplasty: a prospective multivariate regression analysis of 12 independent factors. J Arthroplasty 2010;25:858–64. 10.1016/j.arth.2009.06.011 [DOI] [PubMed] [Google Scholar]
  • 33.Judge A, Batra RN, Thomas GE et al. . Body mass index is not a clinically meaningful predictor of patient reported outcomes of primary hip replacement surgery: prospective cohort study. Osteoarthr Cartil 2014;22:431–9. 10.1016/j.joca.2013.12.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Dowsey MM, Nikpour M, Choong PFM. Outcomes following large joint arthroplasty: does socio-economic status matter? BMC Musculoskelet Disord 2014;15:148 10.1186/1471-2474-15-148 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Hamilton D, Henderson GR, Gaston P et al. . Comparative outcomes of total hip and knee arthroplasty: a prospective cohort study. Postgrad Med J 2012;88:627–31. 10.1136/postgradmedj-2011-130715 [DOI] [PubMed] [Google Scholar]
  • 36.Nilsdotter AK, Lohmander LS. Age and waiting time as predictors of outcome after total hip replacement for osteoarthritis. Rheumatology (Oxford) 2002;41:1261–7. 10.1093/rheumatology/41.11.1261 [DOI] [PubMed] [Google Scholar]
  • 37.Quintana JM, Escobar A, Aguirre U et al. . Predictors of health-related quality-of-life change after total hip arthroplasty. Clin Orthop Relat Res 2009;467:2886–94. 10.1007/s11999-009-0868-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lavernia CJ, Alcerro JC, Contreras JS et al. . Patient perceived outcomes after primary hip arthroplasty: does gender matter? Clin Orthop Relat Res 2011;469:348–54. 10.1007/s11999-010-1503-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Mahomed NN, Liang MH, Cook EF et al. . The importance of patient expectations in predicting functional outcomes after total joint arthroplasty. J Rheumatol 2002;29:1273–9. [PubMed] [Google Scholar]
  • 40.Johansson HR, Bergschmidt P, Skripitz R et al. . Impact of preoperative function on early postoperative outcome after total hip arthroplasty. J Orthop Surg (Hong Kong) 2010;18:6–10. [DOI] [PubMed] [Google Scholar]
  • 41.Fortin PR, Penrod JR, Clarke AE et al. . Timing of total joint replacement affects clinical outcomes among patients with osteoarthritis of the hip or knee. Arthritis Rheum 2002;46:3327–30. 10.1002/art.10631 [DOI] [PubMed] [Google Scholar]
  • 42.Clement ND, Muzammil A, Macdonald D et al. . Socioeconomic status affects the early outcome of total hip replacement. J Bone Joint Surg Br 2011;93:464–9. 10.1302/0301-620X.93B4.25717 [DOI] [PubMed] [Google Scholar]
  • 43.Vogl M, Wilkesmann R, Lausmann C et al. . The impact of preoperative patient characteristics on health states after total hip replacement and related satisfaction thresholds: a cohort study. Health Qual Life Outcomes 2014;12:108 10.1186/s12955-014-0108-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Badura-Brzoza K, Zajac P, Kasperska-Zajac A et al. . Anxiety and depression and their influence on the quality of life after total hip replacement: preliminary report. Int J Psychiatry Clin Pract 2008;12:280–4. 10.1080/13651500802095012 [DOI] [PubMed] [Google Scholar]
  • 45.Lavernia CJ, Villa JM, Contreras JS. Alcohol use in elective total hip arthroplasty: risk or benefit? Clin Orthop Relat Res 2013;471:504–9. 10.1007/s11999-012-2540-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Holstege MS, Lindeboom R, Lucas C. Preoperative quadriceps strength as a predictor for short-term functional outcome after total hip replacement. Arch Phys Med Rehabil 2011;92:236–41. 10.1016/j.apmr.2010.10.015 [DOI] [PubMed] [Google Scholar]
  • 47.Schäfer T, Krummenauer F, Mettelsiefen J et al. . Social, educational, and occupational predictors of total hip replacement outcome. Osteoarthr Cartil 2010;18:1036–42. 10.1016/j.joca.2010.05.003 [DOI] [PubMed] [Google Scholar]
  • 48.Graves CM, Otero JE, Gao Y et al. . Patient reported allergies are a risk factor for poor outcomes in total hip and knee arthroplasty. J Arthroplasty 2014;29(Suppl 9):147–9. 10.1016/j.arth.2014.02.040 [DOI] [PubMed] [Google Scholar]
  • 49.Lavernia CJ, Villa JM, Iacobelli DA et al. . Vitamin D insufficiency in patients with THA: prevalence and effects on outcome. Clin Orthop Relat Res 2014;472:681–6. 10.1007/s11999-013-3172-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Charlson ME, Pompei P, Ales KL et al. . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83. 10.1016/0021-9681(87)90171-8 [DOI] [PubMed] [Google Scholar]
  • 51.van Walraven C, Austin PC, Jennings A et al. . A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data. Med Care 2009;47:626–33. 10.1097/MLR.0b013e31819432e5 [DOI] [PubMed] [Google Scholar]
  • 52.McHorney CA, Ware JEJ, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993;31:247–63. 10.1097/00005650-199303000-00006 [DOI] [PubMed] [Google Scholar]

Articles from BMJ Open are provided here courtesy of BMJ Publishing Group

RESOURCES